CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy.
Li X, Lu M, Yuan M, Ye J, Zhang W, Xu L, Wu X, Hui B, Yang Y, Wei B, Guo C, Wei M, Dong J, Wu X, Gu Y.
Li X, et al. Among authors: zhang w.
Oncoimmunology. 2022 Aug 31;11(1):2118210. doi: 10.1080/2162402X.2022.2118210. eCollection 2022.
Oncoimmunology. 2022.
PMID: 36092638
Free PMC article.